New compounds of the general formula (I), ##STR1## wherein R.sub.1 and R.sub.2 each stand for a saturated or unsaturated, straight-chained or branched alkyl group, an aralkyl group, a saturated or unsaturated cycloalkyl group or an aryl group, or R.sub.1 and R.sub.2 together with the adjacent nitrogen atom may form an optionally substituted heterocyclic group optionally containing a further oxygen or nitrogen hetero atom, But if R.sub.1 stands for methyl, R.sub.2 may only stand for a group other than methyl, are prepared by reacting a compound of the general formula ##STR2## wherein X stands for halogen, with a secondary amine of the general formula (III), r.sub.1 --nh--r.sub.2 (iii) wherein R.sub.1 and R.sub.2 each have the same meanings as defined above. The new compounds of the general formula (I), as well as their pharmaceutical acceptable acid addition salts or quaternary ammonium salts are active primarily in the induction of liver microsomal enzyme, but they also possess antipyretic activity.
通式(I)的新化合物,其中R.sub.1和R.sub.2分别代表饱和或不饱和的直链或支链烷基,芳基烷基,饱和或不饱和的环烷基或芳基,或R.sub.1和R.sub.2与相邻的氮原子一起可以形成一个可选取代的杂环基,可选包含进一步的氧或氮杂原子,但如果R.sub.1代表甲基,则R.sub.2只能代表甲基以外的基团,通过将通式##STR2##其中X代表卤素,与通式(III)的二级胺反应制备而成,r.sub.1-nh-r.sub.2(iii)其中R.sub.1和R.sub.2的含义如上所定义。通式(I)的新化合物及其药学上可接受的酸加盐或季
铵盐主要在诱导肝微粒体酶方面具有活性,但它们也具有解热活性。